Abstract:Aim This study aimed to explore the efficacy and safety of endoscopic submucosal dissection/endoscopic mucosal resection (ESD/EMR), laparoscopic-assisted radical gastrectomy (LARG), and open radical gastrectomy (ORG) in early-stage gastric cancer. Methods A total of 417 patients with early-stage gastric cancer who were admitted in two hospitals from January 1, 2014 to July 31, 2017 were selected; the patients were divided into the ESD/EMR group (139 cases), LARG group (108 cases), and ORG group (170 cases) according to the operation methods used. The baseline data, economic cost of health, oncologic characteristics, postoperative complications, 5-year overall survival and disease-free survival, and risk factors of death were compared and analyzed. Results No significant difference was observed in the baseline data among the three patient groups ( P > 0.05). The total hospitalization days, operation time, postoperative fluid intake time, hospitalization expenses, and proportion of antibiotic use rate in the ESD/EMR group were lesser than those in other groups ( P < 0.05). The LARG group has a longer operation time and higher hospitalization expenses compared with the ORG group ( P < 0.05), but the total hospitalization days, postoperative fluid intake time, proportion of antibiotic use, and lung infection status were consistent. The ESD/EMR group had a lower incidence of incision site infection and postoperative abdominal distension compared with that of the surgery groups ( P < 0.05). Five patients required radical surgery after undergoing ESD/EMR (The patients had residual tissue margin cancer), while none of the patients had switched to ORG during LARG. Surgery had advantages over ESD/EMR in terms of lymph node dissection ( P < 0.05). No significant differences were observed in the postoperative complications such as upper gastrointestinal bleeding, perforation, incision hernia, reoperation and recurrence ( P > 0.05). The 5-year postoperative survival rates of patients in the three groups were 94.2% (ESD/EMR), 93.5% (LARG), and 94.7% (ORG), respectively, with no significant differences ( P > 0.05). The binary logistics multivariate analysis showed that the tumor size, invasion depth, vascular invasion, and differentiated degree were risk factors for death in patients with gastric cancer. Conclusions No significant difference was observed between ESD/EMR and radical surgery. However, standardized criteria for excluding metastatic lymph nodes should be established to promote ESD/EMR.

Bilateral Risk Assessments of Surgery and Nonsurgery Contribute to Providing Optimal Management in Early Gastric Cancers after Noncurative Endoscopic Submucosal Dissection: A Multicenter Retrospective Study of 485 Patients

Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study

475 is Ecura System Useful for Deciding Treatment Strategy after Endoscopic Submucosal Dissection That Does Not Meet the Current Curative Criteria for Early Gastric Cancer? a Comparative Study

A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: “ecura System”

A Recent Argument for the Use of Endoscopic Submucosal Dissection for Early Gastric Cancers

Comparison of the Clinical and Prognosis Risk Factors Between Endoscopic Resection and Radical Gastrectomy for Early-Stage Gastric Cancer

Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series

Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway

Long-term Outcomes after Non-Curative Endoscopic Submucosal Dissection for Early Gastric Cancer According to Hospital Volumes in Japan: a Multicenter Propensity-Matched Analysis

Impact of non-curative endoscopic submucosal dissection on short- and long-term outcome of subsequent laparoscopic gastrectomy for pT1 gastric cancer

Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection

Clinical outcomes of non-curative endoscopic submucosal dissection with negative resected margins for gastric cancer

Is Radical Surgery Necessary in All Patients Who Do Not Meet the Curative Criteria for Endoscopic Submucosal Dissection in Early Gastric Cancer? A Multi-Center Retrospective Study in Japan

Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System

Clinicopathological Outcomes of Patients with Early Gastric Cancer after Non-Curative Endoscopic Submucosal Dissection

Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China

Gastric ESD May Be Useful As Accurate Staging and Decision of Future Therapeutic Strategy

Survival Benefit of Additional Surgery After Non-curative Endoscopic Submucosal Dissection for Early Gastric Cancer: A Propensity Score Matching Analysis

Does Submucosal Operation During Endoscopic Submucosal Dissection In Submucosal Invasive Gastric Cancer Enhance Lymph Node Metastasis And Prognosis?: A Multicenter Retrospective Study In Japan